Ccrt Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
as on 26-05-2024
- Paid Up Capital ₹ 0.13 M
as on 26-05-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -32.45%
(FY 2020)
- Profit 402.83%
(FY 2020)
- Ebitda 457.05%
(FY 2020)
- Net Worth 39.10%
(FY 2020)
- Total Assets 15.86%
(FY 2020)
About Ccrt Laboratories
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Shriram Mengi, Sanjay Koyande, Harsh Koyande, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74900MH2012PTC235481
- Company No.
235481
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Ccrt Laboratories Private Limited offer?
Ccrt Laboratories Private Limited offers a wide range of products and services, including Business Auditing & Valuation, Auditing Services, Concrete, Concrete Mix, Cement, Testing Services, Non Destructive Testing Services.
Who are the key members and board of directors at Ccrt Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Koyande  | Managing Director | 08-Sep-2012 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shriram Mengi | Director | 02-Jan-2014 | Current |
| Harsh Koyande | Additional Director | 09-Nov-2023 | Current |
| Rishi Mengi | Director | 02-Jan-2014 | Current |
| Mohan Jadhav | Director | 01-Oct-2013 | Current |
Financial of Ccrt Laboratories.
Ccrt Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 32.45% decrease. The company also saw a substantial improvement in profitability, with a 402.83% increase in profit. The company's net worth Soared by an impressive increase of 39.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ccrt Laboratories?
In 2019, Ccrt Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ccrt Laboratories?
Unlock and access historical data on people associated with Ccrt Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ccrt Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ccrt Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
